检索结果-南通市图书馆

Chinese Chemical Letters 2006年第4期17卷 525-528页

作者： chun hui zhou hong qiang guo hui jun cao xiao nian li zhong hua ge jie li College of Chemical Engineering and Materials Science Zhejiang University of Technology Hangzhou 310032

Novel layered silinaite has been synthesized using an aqueous mixture of water glass, liOH and NaOH under hydrothermal crystallization. Subsequently transformation of silinaite into mesoporous materials （SDM） was achieved at mild condition using cetyltfimethylammonium bromide as structure-directing agents. The resulting samples were characterized by XRD, SEM, FTIR nitrogen adsorption-desorption isotherms and catalytic performance in bulky molecular involved reaction. The results revealed that synthesized mesoporous materials derived from the silinaite exhibited an ordered hexagonal crystal structure with average pore diameter 2.7 nm and BET surface area 817m^2/g. The SDM-supported ZnCl2 catalyst, prepared by impregnationevaporation method, retained the mesoporous structure and showed high selectivity in alkylation of benzene with benzyl chloride.

关键词： Silinaite mesoporous materials layered solid catalysts characterization.

A practical community-based response strategy to interrupt Ebola transmission in sierra Leone, 2014–2015

在线全文

学校读者我要写书评

暂无评论

Infectious Diseases of Poverty 2016年第1期5卷 670-679页

作者： zhong-jie li Wen-xiao Tu xiao-chun Wang guo-Qing Shi Zun-Dong Yin Hai-jun Su Tao Shen Da-Peng Zhang Jian-Dong li Shan Lv chun-li cao Rui-Qian Xie hong-zhou Lu Rong-Meng Jiang Zheng cao Zhi-jie An Lei-Lei li jie Xu Yan-Wen Xiong Wei Zang Wei Zhang hong-Wei Zhang Wen-Sen Chen hua ling Wen Xu Jian Cai huan-Jin Luo Xue-Sheng Xing Can-jun Zheng qiang Wei Xin-Xu li Mei li Hai Jiang li-Quan Deng Ming-Quan Chen Xiang Huo Feng Xu Xue-hui Lai Xi-Chen Bai Long-jie Ye Jian-Yi Yao Wen-Wu Yin Jiao-Jin Sun lin xiao Fu-qiang liu xiao-qiang liu hong-Wei Fan Zeng-qiang Kou Ji-Kun zhou Hao Zhang Da-Xin Ni Thomas TSamba Qun li hong-jie Yu Yu Wang xiao-Feng liang Division of Infectious Disease Key Laboratory of Surveillance and Early-warning on Infectious DiseaseChinese Center for Disease Control and PreventionBeijingChina Public Health Emergency Center Chinese Center for Disease Control and PreventionBeijingChina National Center for AIDS/STD Control and Prevention Chinese Center for Disease Control and PreventionBeijingChina Chinese Field Epidemiology Training Program Chinese Center for Disease Control and PreventionBeijingChina National Immunization Program Chinese Center for Disease Control and PreventionBeijingChina Bureau of Disease Prevention and Control National Health and Family Planning Commission of the People’s Republic of ChinaBeijingChina National Institute for Viral Disease Control and Prevention Chinese Center for Disease Control and PreventionBeijingChina National Institute of Parasitic Disease Chinese Center for Disease Control and PreventionShanghaiChina Chinese Center for Health Education BeijingChina Department of Infectious Diseases Shanghai Public Health Clinical CenterShanghaiChina Beijing Ditan Hospital Capital Medical UniversityBeijingChina Health News BeijingChina National Institute for Communicable Disease Control and Prevention Chinese Center for Disease Control and PreventionBeijingChina Department of Training Chinese Center for Health EducationBeijingChina Center for Infectious Diseases Beijing Youan HospitalCapital Medical UniversityBeijingChina Infection Management The First Affiliated Hospital of Nanjing Medical UniversityNanjingChina Chongqing Municipal Center for Disease Control and Prevention ChongqingChina Yunnan Provincial Center for Disease Control and Prevention KunmingChina Division of Infectious Disease Control and Prevention Zhejiang Provincial Center for Disease Control and PreventionHangzhouChina Guangdong Provincial Center for Disease Control and Prevention GuangzhouChina Division of Acute Infectious Disease Control and Prevention Hubei Provincial Center for Disease Control and PreventionW

Background:The Ebola virus disease spread rapidly in West Africa in 2014,leading to the loss of thousands of *** engagement was one of the key strategies to interrupt Ebola transmission,and practical community level measures needed to be explored in the field and tailored to the specific context of ***:First,community-level education on Ebola virus disease(EVD)prevention was launched for the community’s social mobilizers in six districts in Sierra Leone beginning in November ***,from January to May of 2015,in three pilot communities,local trained community members were organized to engage in implementation of EVD prevention and transmission interruption measures,by involving them in alert case report,contact tracing,and social *** epidemiological indicators of transmission interruption in three study communities were ***:A total of 6016 community social mobilizers from 185 wards were trained by holding 279 workshops in the six districts,and EVD message reached an estimated 631680 *** three pilot communities,72 EVD alert cases were reported,with 70.8%of them detected by trained local community members,and 14 EVD cases were finally *** tracing detected 64.3%of EVD *** median duration of community infectivity for the cases was 1 *** secondary attack rate was 4.2%,and no third generation of infection was *** health worker was infected,and no unsafe burial and noncompliance to EVD control measures were *** community-based measures were modeled to reduce 77 EVD cases,and the EVD-free goal was achieved four months earlier in study communities than whole country of Sierra ***: The community-based strategy of social mobilization and community engagement was effective in casedetection and reducing the extent of Ebola transmission in a country with weak health system. The successfullypractical experience to reduce the risk of Ebola transmission in the

关键词： Ebola virus disease Community engagement Health education Outbreak control

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia(2021 Edition)

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Military Medical Research 2022年第5期9卷 515-533页

作者： Xian-Tao Zeng Ying-hui Jin Tong-Zu liu Fang-Ming Chen De-Gang Ding Meng Fu Xin-Quan Gu Bang-Min Han Xing huang Zhi Hou Wan-li Hu Xin-li Kang Gong-hui li Jian-Xing li Pei-jun li Chao-Zhao liang Xiu-Heng liu Zhi-Yu liu chun-xiao liu Jiu-Min liu Guang-Heng Luo Yi Luo Wei-jun Qin Jian-hong Qiu Jian-Xin Qiu Xue-jun Shang Ben-Kang Shi Fa Sun guo-Xiang Tian Ye Tian Feng Wang Feng Wang Yin-huai Wang Yu-jie Wang Zhi-Ping Wang zhong Wang qiang Wei Min-hui xiao Wan-Hai Xu Fa-Xian Yi Chao-Yang Zhu Qian-Yuan Zhuang li-Qun zhou xiao-Feng Zou nian-Zeng Xing Da-lin He Xing-huan Wang 无 Department of Urology Institute of UrologyZhongnan Hospital of Wuhan UniversityWuhan430071China Center for Evidence-Based and Translational Medicine Zhongnan Hospital of Wuhan UniversityWuhan430071China Department of Urology Tianjin Third Central Hospital Affiliated To Nankai UniversityTianjin300170China Department of Urology Henan Provincial People’s HospitalZhengzhou University People’s HospitalZhengzhou450003China Department of Urology Beijing Tsinghua Changgung HospitalSchool of Clinical MedicineTsinghua UniversityBeijing102218China Department of Urology China-Japan Union Hospital of Jilin UniversityChangchun130033China Department of Urology Shanghai General HospitalShanghai Jiao Tong University School of MedicineShanghai200080China Department of Urology Qinghai University Affiliated HospitalXi’ning810012China Department of Urology People’s Hospital of Hainan ProvinceHainan Affiliated Hospital of Hainan Medical University HaikouHaikou570311China Department of Urology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou310016China Department of Urology General Hospital of Ningxia Medical UniversityYinchuan750003China Department of Urology The First Affiliated Hospital of Anhui Medical UniversityHefei230022China Department of Urology Renmin Hospital of Wuhan UniversityWuhan430060China Department of Urology The Second Hospital of Dalian Medical UniversityDalian116023LiaoningChina Department of Urology Zhujiang Hospital of Southern Medical UniversityGuangzhou510282China Department of Urology Guangdong Provincial People’s HospitalGuangdong Academy of Medical SciencesGuangzhou510080China Department of Urology Surgery Guizhou Province People’s HospitalGuiyang550002China Department of Urology Xijing Hospital of Air Force Military Medical UniversityXi’an710032China Department of Urology The 980St Hospital of the PLA Joint Logistics Support Force(Bethune International Peace Hospital of PLA)Shijiazhuang050082China Department of Urology

Benign prostatic hyperplasia (BPH) is highly prevalent among older men, impacting on their quality of life, sexual function, and genitourinary health, and has become an important global burden of disease. Transurethral plasmakinetic resection of prostate (TUPKP) is one of the foremost surgical procedures for the treatment of BPH. It has become well established in clinical practice with good efficacy and safety. In 2018, we issued the guideline “2018 Standard Edition”. However much new direct evidence has now emerged and this may change some of previous recommendations. The time is ripe to develop new evidence-based guidelines, so we formed a working group of clinical experts and methodologists. The steering group members posed 31 questions relevant to the management of TUPKP for BPH covering the following areas: questions relevant to the perioperative period (preoperative, intraoperative, and postoperative) of TUPKP in the treatment of BPH, postoperative complications and the level of surgeons’ surgical skill. We searched the literature for direct evidence on the management of TUPKP for BPH, and assessed its certainty generated recommendations using the grade criteria by the European Association of Urology. Recommendations were either strong or weak, or in the form of an ungraded consensus-based statement. Finally, we issued 36 statements. Among them, 23 carried strong recommendations, and 13 carried weak recommendations for the stated procedure. They covered questions relevant to the aforementioned three areas. The preoperative period for TUPKP in the treatment of BPH included indications and contraindications for TUPKP, precautions for preoperative preparation in patients with renal impairment and urinary tract infection due to urinary retention, and preoperative prophylactic use of antibiotics. Questions relevant to the intraoperative period incorporated surgical operation techniques and prevention and management of bladder explosion. The application to different

关键词： Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia Recommendation Treatment Guideline

Consensus statement on layout and delivery of automatic external defibrillator in China

在线全文

学校读者我要写书评

暂无评论

Journal of Hainan Medical University 2020年第15期26卷 18-23页

作者： Yu cao Song Chen Yan-Fen Chai xiao-hui Chen Yu-guo Chen Shao-Wen Cheng Wen-Wei Cheng Bang-Han Ding Yang Deng jie Fu Bang-Jiang Fang Mai-Ying Fan li Gui Ping Gong Wei guo Shu-Bin guo liang huang Ji-Yuan Han zhong Ji Xian-Fei Ji Xin-Cai Ji hong-Xu Jin Xin-jun Jiang Wang-Xiang Jiang Jia-liang liu xiao-Ran liu Zhi liu Chuan-Zhu Lv Feng Lu Tan-Shi li Xin li Yong li Shang-Lun li Shuang-Ming li xiao-Gang li Bao-jun li Pei-Wu li chun-Sheng li Zhi-jun li Chang-Luo li Xiang-Min li Yin-Ping li Zong-jun Lu Zu-Xun Lu zhong-Qiu Lu Zhi-Qian Luo xiao-Xing liao Jian-Bo Lei Tao Ma Yu Ma Yue-Feng Ma Qing-Bian Ma lin-Hao Ma jun-Qi Ma Shi-Nan Nie jie-Miao Ou-Yang Peng Peng Qiao Pei Shu-Ming Pan guo-zhong Qing li-jie Qin Wu-Ying Qiao Fei Shao Wei Song Xing-Yue Song Zhen-Ju Song Rong-Ju Sun De-Ya Shang Du-Juan Sha Gui-Lan Tao guo-Gang Tian Ying-Ping Tian Jian-Guang Tian Chao-Yang Tong Zi-Ren Tang Meng-Xiong Tang guo-Ping Wu Zhi Wan Tao Wang Xin Wang Peng Wang zhong Wang Tong Wang Ri-Xing Wang Yi-Xin Wang xiao-Dan Wang ling Wu Wei Wei hua Xiang Feng Xu jun Xu jie Xu Miao-Rong Xie Shuo-Gui Xu Tie Xu Feng Yu Wen Yi li-Shan Yang Shi-Jiao Yan Jin-Jian Yao Shou-chun Yan Xue-zhong Yu Xian-Zhi Ye Xian-liang Yan Fu-Bing zhou Rong-Bin zhou Ming zhou qiang zhou Jin zhou Ping zhou Chang-Ju Zhu hua-Dong Zhu Ji-hong Zhu hong Zhang Mao Zhang hua Zhang Na Zhang guo-qiang Zhang guo-Xiu Zhang Jin-Song Zhang Wen-Wu Zhang Wen-zhong Zhang Jian-Feng Zhang Yi-Min Zhu jun Zeng Yuan Zheng Zhi-jie Zheng Shen Zhao Yan Zhao Min Zhao Bin Zhao xiao-Dong Zhao xiao-Jing Zhao hong-Ke Zeng Sheng-qiang Zou The Chinese Society of Emergency Medicine Research Unit of Island Emergency Medicine Chinese Academy of Medical SciencesHainan Medical University Key Laboratory of Emergency and Trauma of Ministry of Education Hainan Medical UniversityHaikouHainanChina Emergency and Trauma College Hainan Medical UniversityHaikouHainanChina Department of Emergency Hainan Clinical Research Center for Acute and Critical DiseasesThe Second Affiliated Hospital of Hainan Medical UniversityHaikouHainanChina Key Laboratory of Hainan Trauma and Disaster Rescue Key Laboratory of Trauma of Hainan Medical University

*** Sudden cardiac death(SCD)refers to sudden death due to a variety of cardiac *** is manifested as a sudden loss of consciousness,cardiac arrest,and respiratory arrest and generally shows early symptoms that are atypical and not easily detected[1].According to a recent study,nearly 544000 patients suffer from SCD every year in China[2].

关键词： cardiac death respiratory

The DIRECT consortium and the REST-meta-MDD project:towards neuroimaging biomarkers of major depressive disorder

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Psychoradiology 2022年第1期2卷 32-42页

作者： xiao Chen Bin Lu hui-Xian li Xue-Ying li Yu-Wei Wang Francisco Xavier Castellanos li-Ping cao Ning-Xuan Chen Wei Chen Yu-Qi Cheng Shi-Xian Cui Zhao-Yu Deng Yi-Ru Fang Qi-Yong Gong Wen-Bin guo Zheng-Jia-Yi Hu li Kuang Bao-Juan li Le li Tao li Tao lian Yi-Fan liao Yan-Song liu Zhe-Ning liu Jian-Ping Lu Qing-hua Luo hua-Qing Meng Dai-hui Peng Jiang Qiu Yue-Di Shen Tian-Mei Si Yan-Qing Tang Chuan-Yue Wang Fei Wang hua-Ning Wang Kai Wang Xiang Wang Ying Wang Zi-Han Wang xiao-Ping Wu chun-Ming Xie Guang-Rong Xie Peng Xie Xiu-Feng Xu hong Yang Jian Yang Shu-Qiao Yao Yong-qiang Yu Yong-Gui Yuan Ke-Rang Zhang Wei Zhang Zhi-jun Zhang jun-Juan Zhu Xi-nian Zuo Jing-Ping Zhao Yu-Feng Zang the DIRECT consortium Chao-Gan Yan CAS Key Laboratory of Behavioral Science Institute of PsychologyChinese Academy of SciencesBeijing 100101China International Big-Data Center for Depression Research Chinese Academy of SciencesBeijing 100101China Magnetic Resonance Imaging Research Center Institute of PsychologyChinese Academy of SciencesBeijing 100101China Department of Psychology University of Chinese Academy of SciencesBeijing 100049China Sino-Danish College University of Chinese Academy of SciencesBeijing 101408China Sino-Danish Center for Education and Research Graduate University of Chinese Academy of SciencesBeijing 101408China Department of Child and Adolescent Psychiatry NYU Grossman School of MedicineNew YorkNY 10016USA Nathan Kline Institute for Psychiatric Research OrangeburgNew YorkNY 10962USA 9Affiliated Brain Hospital of Guangzhou Medical UniversityGuangzhou 510370China Capital Normal University Beijing 100089China Department of Psychiatry Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhou 310020ZhejiangChina Department of Psychiatry First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Shanghai Mental Health Center Shanghai Jiao Tong University School of MedicineShanghai 200030China huaxi MR Research Center(HMRRC) Department of RadiologyWest China Hospital of Sichuan UniversityChengduSichuan 610044China Research Unit of Psychoradiology Chinese Academy of Medical SciencesChengduSichuan 610052China Department of Psychiatry and National Clinical Research Center for Mental DisordersThe Second Xiangya Hospital of Central South UniversityChangsha 410011HunanChina Department of Psychiatry The First Affiliated Hospital of Chongqing Medical UniversityChongqing 400042China Xijing Hospital of Air Force Military Medical University Xi’anShaanxi 710032China Center for Cognitive Science of Language Beijing Language and Culture UniversityBeijing 100083China Affiliated Mental Health Center&Hangzhou Seventh People’s Hospital Zhejiang University School of

Despite a growing neuroimaging literature on the pathophysiology of major depressive disorder(MDD),repro-ducible findings are lacking,probably reflecting mostly small sample sizes and heterogeneity in analytic *** address these issues,the Depression Imaging REsearch ConsorTium(DIRECT)was *** REST-meta-MDD project,pooling 2428 functional brain images processed with a standardized pipeline across all participating sites,has been the first effort from *** this review,we present an overview of the moti-vations,rationale,and principal findings of the studies so far from the REST-meta-MDD *** from the first round of analyses of the pooled repository have included alterations in functional connectivity within the default mode network,in whole-brain topological properties,in dynamic features,and in functional *** well-powered exploratory observations have also provided the basis for future longitudinal hypothesis-driven *** these fruitful explorations,DIRECT has proceeded to its second stage of data sharing that seeks to examine ethnicity in brain alterations in MDD by extending the exclusive Chinese original sample to other ethnic groups through international collaborations.A state-of-the-art,surface-based preprocessing pipeline has also been introduced to improve *** images from patients with bipolar disorder and schizophrenia will be included to identify shared and unique abnormalities across diag-nosis *** addition,large-scale longitudinal studies targeting brain network alterations following antidepressant treatment,aggregation of diffusion tensor images,and the development of functional magnetic resonance imaging-guided neuromodulation approaches are *** these endeavours,we hope to accelerate the translation of functional neuroimaging findings to clinical use,such as evaluating longitudinal effects of antidepressant medications and developing individualized

关键词： major depressive disorder DIRECT R-fMRI database neuroimaging

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中成药临床应用专家共识(第一版)

中国药学杂志 2022年第6期57卷 502-506页

作者：曹俊岭李学林李春晓薛春苗陈树和高山高艳关胜江郭桂明何婷华国栋黄明政孔祥文李丹李国辉李亚秋林华刘芳刘力刘效栓罗君凌霄梅全喜年华欧阳荣沈夕坤孙洪胜谭喜莹唐洪梅唐进法田杰涂禾汪永忠王丽霞王世伟夏杰晏军杨敏杨新建姚毅岳宝森赵生俊赵旭赵艳玲郑敏霞周训蓉邹爱英北京中医药大学东方医院北京100078 河南中医药大学第一附属医院郑州450004 北京中医药大学东直门医院北京100700 湖北省中医院武汉430060 黑龙江省中医院哈尔滨150036 吉林省中医院长春130021 河北省中医院石家庄050013 首都医科大学附属北京中医医院北京100010 广西中医药大学第一附属医院南宁530022 北京中医药大学第三附属医院北京100029 福州市中医院福州350001 中国医学科学院肿瘤医院北京100021 辽宁中医药大学附属医院沈阳110033 广东省中医院广州510120 天津中医药大学第一附属医院天津300073 上海中医药大学附属曙光医院上海201203 甘肃省中医院兰州730050 贵州中医药大学第一附属医院贵阳550001 深圳市宝安纯中医治疗医院广东深圳518038 上海中医药大学附属岳阳医院上海200083 湖南中医药大学第一附属医院长沙410021 江苏省苏州市中医医院江苏苏州215007 山东省中医院济南250013 江苏省中医院南京210004 广州中医药大学第一附属医院广州510450 宁夏回族自治区中医医院暨中医研究院银川750001 四川省骨科医院成都610041 安徽省中医院合肥230601 中国中医科学院广安门医院北京100053 山西省中医院太原030012 云南省中医院昆明650021 重庆市中医院重庆400011 天津中医研究院附属医院天津300120 陕西省西安市中医院西安710021 新疆自治区自治区中医医院乌鲁木齐830002 河南省中医院郑州450053 解放军第五医学中心北京100039 浙江省中医院杭州310003 贵州中医药大学第二附属医院贵阳550003 天津中医药大学第二附属医院天津300150

中成药是我国医疗卫生体系中药品的一大特色和优势,其剂型多样,品种繁多,临床应用十分广泛。据相关统计,我国获批国产中药批文共59474个,共涉及中成药品种9629个,剂型42种。综合性医院中,西医所开出的中成药占医疗机构全部售出中成药的8... 详细信息

中成药是我国医疗卫生体系中药品的一大特色和优势,其剂型多样,品种繁多,临床应用十分广泛。据相关统计,我国获批国产中药批文共59474个,共涉及中成药品种9629个,剂型42种。综合性医院中,西医所开出的中成药占医疗机构全部售出中成药的84%[1-2]。随着中成药临床使用范围的扩大,安全性问题也日趋严峻,除中成药的质量状况外[3],临床合理应用方面更为明显,如用药过量,重复用药、联合用药不当,超用药禁忌、功效及毒副作用考虑不周等[4-5]。

关键词：中成药临床应用合理使用专家共识

CEPC Technical Design Report

在线全文

学校读者我要写书评

暂无评论

Radiation Detection Technology and Methods 2024年第1期8卷 I0003-I0016,1-1091页

作者： Waleed Abdallah Tiago Carlos Adorno de Freitas Konstantin Afanaciev Shakeel Ahmad Ijaz Ahmed xiaocong Ai Abid Aleem Wolfgang Altmannshofer Fabio Alves Weiming An Rui An Daniele Paolo Anderle Stefan Antusch Yasuo Arai Andrej Arbuzov Abdesslam Arhrib Mustafa Ashry Sha Bai Yu Bai Yang Bai Vipul Bairathi Csaba Balazs Philip Bambade Yong Ban Tripamo Bandyopadhyay Shou-Shan Bao Desmond P.Barber Ayse Bat Varvara Batozskaya Subash Chandra Behera Alexander Belyaev Michele Bertucci xiao-jun Bi Yuanjie Bi Tianjian Bian Fabrizio Bianchi Thomas Biekotter Michela Biglietti Shalva Bilanishvili Deng Binglin Denis Bodrov Anton Bogomyagkov Serge Bondarenko Stewart Boogert Maarten Boonekamp Marcello Borri Angelo Bosotti Vincent Boudry Mohammed Boukidi Igor Boyko Ivanka Bozovic Giuseppe Bozzi Jean-Claude Brient Anastasiia Budzinskaya Masroor Bukhari Vladimir Bytev Giacomo Cacciapaglia hua Cai Wenyong Cai Wujun Cai Yijian Cai Yizhou Cai Yuchen Cai Haiying Cai huacheng Cai Lorenzo Calibbi junsong Cang guofu cao Jianshe cao Antoine Chance Xuejun Chang Yue Chang Zhe Chang Xinyuan Chang Wei Chao Auttakit Chatrabhuti Yimin Che Yuzhi Che Bin Chen Danping Chen Fuqing Chen Fusan Chen Gang Chen guoming Chen hua-Xing Chen huirun Chen Jinhui Chen Ji-Yuan Chen Kai Chen Mali Chen Mingjun Chen Mingshui Chen Ning Chen Shanhong Chen Shanzhen Chen Shao-Long Chen Shaomin Chen Shiqiang Chen Tianlu Chen Wei Chen Xiang Chen xiaoyu Chen Xin Chen Xun Chen Xurong Chen Ye Chen Ying Chen Yukai Chen Zelin Chen Zilin Chen Gang Chen Boping Chen chunhui Chen Hok Chuen Cheng huajie Cheng Shan Cheng Tongguang Cheng Yunlong Chi Pietro Chimenti Wen Han Chiu Guk Cho Ming-chung Chu xiaotong Chu Ziliang Chu Guglielmo Coloretti Andreas Crivellin Hanhua Cui xiaohao Cui Zhaoyuan Cui Brunella D'Anzi ling-Yun Dai Xinchen Dai Xuwen Dai Antonio De Maria Nicola De Filippis Christophe De La Taille Francesca De Mori Chiara De Sio Elisa Del Core Shuangxue Deng Wei-Tian Deng Zhi Deng Ziyan Deng Bhupal Dev Tang Dewen Biagio Di Micco Ran Ding Siqin Dingl Yadong Ding Haiyi Dong Jianin AGH University of Science and Technology Faculty of Physics and Applied Computer ScienceKrakow Anhui University HefeiAnhui Applied Physics Department Federal Urdu University of ArtsScience and TechnologyIslamabad Banaras Hindu University Institute of ScienceVaranasi Bandirma Onyedi Eylul University Bandirma Beihang University Beijing Beijing Computational Science Research Center Beijing Beijing Conveyi LTD Beijing Beijing Glass Research Institute Co. LtdBeijing Beijing Institute of Technology Beijing Beijing Normal University Beijing Brown University ProvidenceRI Budker Institute of Nuclear Physics Novosibirsk Cadi Ayyad University Laboratory of Fundamental and Applied PhysicsPolydisciplinary FacultyMarrakech Cairo University Giza Center for Theory and Computation National Tsing Hua UniversityHsinchu Central China Normal University WuhanHubei Central South University ChangshaHunan Centro de Fisica Teorica de Particulas Universidade Tecnica de LisboaLisboa Chengdu KaitengSifang Digital Radio&TV Equipment Co. LtdChengduSichuan China academy of engineering physics MianyangSichuan China building materials academy Beijing China Center of Advanced Science and Technology Beijing China Institute of Atomic Energy Beijing China Jiliang University HangzhouZhejiang China Nuclear Instrument CO. LTDBeijing China University of geosciences Beijing China University of geosciences WuhanHubei China University of Mining and Technology XuzhouJiangsu China West Normal University NanchongSichuan Chongqing University Department of PhysicsChongqing Chulalongkorn University Bangkok City University of hong Kong Department of PhysicsHong Kong Cockcroft Institute Daresbury Cornell University IthacaNY CPPM(AMU/IPhU&CNRS/INP) Marseille Dalian Minzu University DalianLiaoning Dalian University of Technology Department of PhysicsDalian Deutsches Elektronen-Synchrotron DESY Hamburg Dzhelepov Laboratory of Nuclear Problems of Joint Institute for Nuclear Research(DLNP JINR) Dubna East China University Of Science And Technol

The Circular Electron Positron Collider(CEPC)is a large scientific project initiated and hosted by China,fostered through extensive collaboration with international *** complex comprises four accelerators:a 30 geV linac,a 1.1 geV Damping Ring,a Booster capable of achieving energies up to 180 geV,and a Collider operating at varying energy modes(Z,W,H,and tt).The linac and Damping Ring are situated on the surface,while the subterranean Booster and Collider are housed in a 100 km circumference underground tunnel,strategically accommodating future expansion with provisions for a potential Super Proton Proton Collider(SPPC).The CEPC primarily serves as a Higgs *** its baseline design with synchrotron radiation(SR)power of 30 MW per beam,it can achieve a luminosity of 5×10^(34)cm^(-2)s^(-1)per interaction point(IP),resulting in an integrated luminosity of 13 ab^(-1)for two IPs over a decade,producing 2.6 million Higgs *** the SR power to 50 MW per beam expands the CEPC's capability to generate 4.3 million Higgs bosons,facilitating precise measurements of Higgs coupling at sub-percent levels,exceeding the precision expected from the HL-LHC by an order of *** Technical Design Report(TDR)follows the Preliminary Conceptual Design Report(Pre-CDR,2015)and the Conceptual Design Report(CDR,2018),comprehensively detailing the machine's layout,performance metrics,physical design and analysis,technical systems design,R&D and prototyping efforts,and associated civil engineering ***,it includes a cost estimate and a preliminary construction timeline,establishing a framework for forthcoming engineering design phase and site selection *** is anticipated to begin around 2027-2028,pending government approval,with an estimated duration of 8 *** commencement of experiments and data collection could potentially be initiated in the mid-2030s.

关键词： initiated exceeding precise

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

注射用丹参多酚酸盐的临床应用综合评价

中国药学杂志 2021年第6期56卷 507-514页

作者：韩晟赵熙子史录文林丽开李大魁陈凯先宣利江马传江马海英方唯一王丽霞文爱东付秀娟左燕刘小玲刘向红刘国强朱珠陈万生陈维红吴方建吴玉波吴晖张伟张毕奎林慧周国华欧阳荣胡元会姜明燕赵春景贾乐川晋月萍唐洪梅曹俊岭梁春商洪才董占军董吁钢翟所迪北京大学医药管理国际研究中心北京100191 武汉大学中南医院武汉大学医院管理研究所武汉430071 北京协和医院北京100730 中国科学院上海药物研究所上海201203 山东中医药大学附属医院济南250014 中国医科大学附属第四医院沈阳110000 复旦大学附属华东医院上海200030 中国中医科学院广安门医院北京100053 中国人民解放军空军军医大学第一附属医院西安710032 吉林大学第二医院长春130041 陕西省人民医院西安710068 内蒙古自治区人民医院呼和浩特010017 山东大学齐鲁医院济南250012 河北医科大学第三医院石家庄050051 海军军医大学第二附属医院上海200003 山西白求恩医院(山西医学科学院) 太原030032 长江航运总医院武汉430015 哈尔滨医科大学附属第四医院哈尔滨150001 昆明医科大学第一附属医院昆明650032 河南省人民医院郑州450003 中南大学湘雅二医院长沙410011 海南省药学会海口570102 南京大学医学院附属金陵医院南京210000 湖南中医药大学第一附属医院长沙410007 中国医科大学附属第一医院沈阳110001 重庆医科大学附属第二医院重庆400010 宁夏医科大学总医院银川750004 山西医科大学第一医院太原030001 广州中医药大学第一附属医院广州510405 北京中医药大学东方医院北京100078 北京中医药大学东直门医院北京100007 河北省人民医院石家庄050051 中山大学附属第一医院广州510080 北京大学第三医院北京100191

目的以注射用丹参多酚酸盐为例,探索中药注射剂临床应用的综合评价方法,为今后相关工作的开展和完善提供参考。方法通过文献检索和获取相关文献资料,从有效性、安全性、经济性、顺应性和标签信息等方面对注射用丹参多酚酸盐进行系统综... 详细信息

目的以注射用丹参多酚酸盐为例,探索中药注射剂临床应用的综合评价方法,为今后相关工作的开展和完善提供参考。方法通过文献检索和获取相关文献资料,从有效性、安全性、经济性、顺应性和标签信息等方面对注射用丹参多酚酸盐进行系统综合评价。结果除说明书适应证外,丹参多酚酸盐在心血管疾病、脑血管疾病等多种超说明书适应证中都存在具有一定质量的临床研究证据;在安全性、经济性方面的文献证据较为丰富。结论注射用丹参多酚酸盐在有效性、安全性及经济性等方面的临床研究证据较多,且具有一定的体系。但作为一个临床应用大品种,该药依然需要在一些方面做出更多的研究努力。

关键词：丹参酚酸B镁药品综合评价中药注射剂有效性安全性

在线全文

学校读者我要写书评

暂无评论

注射用丹参多酚酸盐的药学综合评价

中国药学杂志 2021年第5期56卷 422-428页

作者：韩晟赵熙子史录文林丽开李大魁陈凯先宣利江马传江马海英方唯一王丽霞文爱东付秀娟左燕刘小玲刘向红刘国强朱珠陈万生陈维红吴方建吴玉波吴晖张伟张毕奎林慧周国华欧阳荣胡元会姜明燕赵春景贾乐川晋月萍唐洪梅曹俊岭梁春商洪才董占军董吁钢翟所迪北京大学医药管理国际研究中心北京100191 武汉大学中南医院武汉大学医院管理研究所武汉430071 北京协和医院北京100730 中国科学院上海药物研究所上海201203 山东中医药大学附属医院济南250014 中国医科大学附属第四医院沈阳110000 复旦大学附属华东医院上海200030 中国中医科学院广安门医院北京100053 中国人民解放军空军军医大学第一附属医院西安710032 吉林大学第二医院长春130041 陕西省人民医院西安710068 内蒙古自治区人民医院呼和浩特010017 山东大学齐鲁医院济南250012 河北医科大学第三医院石家庄050051 上海长征医院上海200003 山西白求恩医院(山西医学科学院) 太原030032 长江航运总医院武汉430015 哈尔滨医科大学附属第四医院哈尔滨150001 昆明医科大学第一附属医院昆明650032 河南省人民医院郑州450003 中南大学湘雅二医院长沙410011 海南省药学会海口570102 南京大学医学院附属金陵医院南京210000 湖南中医药大学第一附属医院长沙410007 中国医科大学附属第一医院沈阳110001 重庆医科大学附属第二医院重庆400000 宁夏医科大学总医院宁夏750004 山西医科大学第一医院太原030001 广州中医药大学第一附属医院广州510405 北京中医药大学东方医院北京100078 北京中医药大学东直门医院北京100007 河北省人民医院石家庄050051 中山大学附属第一医院广州510080 北京大学第三医院北京100191

目的以注射用丹参多酚酸盐为例,探索中药注射剂的综合评价方法,为今后相关工作的开展和完善提供参考。方法通过文献检索和获取相关文献资料,从药学特性、质量等方面对注射用丹参多酚酸盐进行药学综合评价。结果在有效成分和药物作用机... 详细信息

目的以注射用丹参多酚酸盐为例,探索中药注射剂的综合评价方法,为今后相关工作的开展和完善提供参考。方法通过文献检索和获取相关文献资料,从药学特性、质量等方面对注射用丹参多酚酸盐进行药学综合评价。结果在有效成分和药物作用机制方面,丹参多酚酸盐已经进行了大量的基础研究。质量方面的文献证据也较为丰富。结论注射用丹参多酚酸盐在药学特性方面研究探索面非常广,相关基础研究还有待进一步探索。

关键词：丹参酚酸B 综合评价中药注射剂药学特性

在线全文

学校读者我要写书评

暂无评论

医疗机构中成药遴选专家共识(第一版)

中国药学杂志 2022年第18期57卷 1580-1586页

作者：程杰关胜江曹俊岭陈树和高山高雪亮郭晓秋韩晟何婷孔祥文李国辉李学林李亚秋林华刘力马致洁欧阳荣沈夕坤孙洪胜唐洪梅唐进法王乐王世伟吴剑坤辛义周薛春苗闫国强晏军杨毅恒姚毅伊博文赵奎军赵旭张颖郑倩赵生俊无河北省中医院石家庄05001 北京中医药大学东直门医院北京100700 湖北省中医院武汉430060 黑龙江省中医院哈尔滨150036 江西省中医院南昌330006 北京大学医药管理国际研究中心北京100191 北京中医药大学第三附属医院北京100029 中国医学科学院肿瘤医院北京100021 河南中医药大学第一附属医院郑州450000 辽宁中医药大学第一附属医院沈阳110033 广东省中医院广州510120 上海中医药大学曙光医院上海200021 首都医科大学附属友谊医院北京100050 湖南中医药大学第一附属医院长沙410000 江苏省苏州市中医院江苏苏州215002 山东省中医院济南250011 广州中医药大学第一附属医院广州510405 山西省中医院太原030012 首都医科大学附属北京市中医医院北京100010 沧州中西医结合医院河北沧州006100 北京大学第三医院北京100083 江苏省中医院南京210029 中国中医科学院西苑医院北京100080 河南省中医院郑州450002 中国中医科学院眼科医院北京100040 石家庄市中医院石家庄050051 新疆维吾尔自治区中医院乌鲁木齐830000

中医药是我国医药卫生体系的重要组成部分,中医药有其独特的理论体系、临床实践及科学研究。中成药是在中医药理论指导下,以中药饮片为原料,按规定处方和制剂工艺加工而成的中药制剂,具有传承与创新并重的属性。随着中医药在疾病治疗中... 详细信息

中医药是我国医药卫生体系的重要组成部分,中医药有其独特的理论体系、临床实践及科学研究。中成药是在中医药理论指导下,以中药饮片为原料,按规定处方和制剂工艺加工而成的中药制剂,具有传承与创新并重的属性。随着中医药在疾病治疗中的广泛应用,中成药品种不断研发上市,为临床提供了更多的用药选择。国家集中采购药品政策的落地执行,也促使医疗机构不断调整药品供应目录。因此,科学、规范、合理地开展药品遴选是目前许多医疗机构不得不面对的问题。

关键词：中成药药品临床综合评价药品遴选传承性专家共识